
正在為您準備內容...

正在為您準備內容...
成份 · Ingredient
維奈托克
維奈托克是一種強效的B細胞淋巴瘤-2(BCL-2)蛋白抑制劑,屬於吡咯並吡啶類化合物。它通過抑制抗凋亡蛋白來誘導癌細胞凋亡,主要用於治療帶有17p缺失的慢性淋巴性白血病及其他血液惡性腫瘤。
Venetoclax is a member of the class of pyrrolopyridines that is a potent inhibitor of the antiapoptotic protein B-cell lymphoma 2. It is used for treamtment of chronic lymphocytic leukemia with 17p deletion. It has a role as a B-cell lymphoma 2 inhibitor, an antineoplastic agent and an apoptosis inducer. It is an aromatic ether, a C-nitro compound, a pyrrolopyridine, a N-alkylpiperazine, a N-arylpiperazine, a member of oxanes, a member of monochlorobenzenes and a N-sulfonylcarboxamide.
藥品資料來源:香港衞生署藥物辦公室 · 化學資料來源:PubChem (NIH) · 資料僅供參考,不構成醫療建議